• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Southworth Associates Announces Acquisition Of Scott Gilbert’s “IOP Consulting” And Appointment Of New Managing Partner

Share:

June 3, 2019

Today, Southworth Associates announced it has acquired Scott Gilbert’s Mississippi based, behavioral health consulting firm, IOP Consulting. Additionally, Southworth Associates announces that Chad Grimm, former CEO of Longbranch Healthcare, will be joining Scott and Ben. This new partnership will increase the size and capabilities of Southworth Associates. Key goals include expansion of existing services such as monitoring, interventions, conferences and development of strategic consulting services and technological tools. The acquisition also includes the purchase of a proprietary behavioral health financial management application; developed by, Scott Gilbert and Chad Grimm.

Benjamin Seymour of Southworth Associates released the following statement: “I am excited to have Scott, Chad and the IOP Consulting team coming on board. Since taking over in 2017, I knew Southworth needed more bandwidth to tackle the new projects and goals of the company. It’s no secret behavioral health is in a large transition and rebuilding phase. We see opportunities to help providers tell the story of how they help the patients they serve. The over-arching goal is to make Southworth Associates a resource for not only families, but providers as well.”

Date: June 03, 2019

Source: Cision

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Aqilion sells holdings in project company Belina to its founderAqilion sells holdings in project company Belina to its founder
  • BioNTech to Acquire Neon to Strengthen Global Leadership Position in T Cell TherapiesBioNTech to Acquire Neon to Strengthen Global Leadership Position in T Cell Therapies
  • Amryt Pharma : to expand rare disease portfolio with $311m Aegerion mergerAmryt Pharma : to expand rare disease portfolio with $311m Aegerion merger
  • Novanta Completes Acquisition of Motion SolutionsNovanta Completes Acquisition of Motion Solutions
  • TestCard at-home UTI test to launch in the UK in AugustTestCard at-home UTI test to launch in the UK in August
  • Bye-bye, solo Express Scripts: What does the Cigna buyout mean for pharma?Bye-bye, solo Express Scripts: What does the Cigna buyout mean for pharma?
  • COVID-19 Spikes Deaconess Health Adoption of Remote Medical ExamsCOVID-19 Spikes Deaconess Health Adoption of Remote Medical Exams
  • Almirall and Wuxi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology DiseasesAlmirall and Wuxi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications